CA2495563A1 - Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et leurs procedes d'utilisation - Google Patents

Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et leurs procedes d'utilisation Download PDF

Info

Publication number
CA2495563A1
CA2495563A1 CA002495563A CA2495563A CA2495563A1 CA 2495563 A1 CA2495563 A1 CA 2495563A1 CA 002495563 A CA002495563 A CA 002495563A CA 2495563 A CA2495563 A CA 2495563A CA 2495563 A1 CA2495563 A1 CA 2495563A1
Authority
CA
Canada
Prior art keywords
novx
polypeptide
protein
nucleic acid
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002495563A
Other languages
English (en)
Inventor
Mei Zhong
Weizhen Ji
Xiaojia Guo
Daniel K. Rieger
Muralidhara Padigaru
Rachel Malcolm
Kimberly A. Spytek
David W. Anderson
Linda Gorman
Elina Catterton
John R. Macdougall
David J. Stone
Shlomit R. Edinger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
CuraGen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/236,392 external-priority patent/US20040067490A1/en
Priority claimed from US10/242,943 external-priority patent/US20030087412A1/en
Priority claimed from US10/635,149 external-priority patent/US20050049192A1/en
Application filed by CuraGen Corp filed Critical CuraGen Corp
Publication of CA2495563A1 publication Critical patent/CA2495563A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

L'invention concerne des séquences d'acides nucléiques codant pour de nouveaux polypeptides. L'invention concerne également des polypeptides codés par lesdites séquences d'acides nucléiques, et des anticorps qui se lient de manière immunospécifique au polypeptide ainsi que des dérivés, des variantes, des mutants, ou des fragments du nouveau polypeptide, polynucléotide ou anticorps spécifiques dudit polypeptide. L'invention concerne, en outre, des vecteurs, des cellules hôtes, des anticorps et des méthodes de recombinaison permettant de produire lesdits polypeptides et polynucléotides ainsi que des méthodes permettant de les utiliser. L'invention concerne enfin des méthodes thérapeutiques, diagnostiques et de recherche à des fins de diagnostic, de traitement et de prévention de troubles impliquant l'un quelconque de ces nouveaux acides nucléiques et protéines humains.
CA002495563A 2002-08-07 2003-08-07 Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et leurs procedes d'utilisation Abandoned CA2495563A1 (fr)

Applications Claiming Priority (25)

Application Number Priority Date Filing Date Title
US40159702P 2002-08-07 2002-08-07
US60/401,597 2002-08-07
US40220502P 2002-08-09 2002-08-09
US40220902P 2002-08-09 2002-08-09
US60/402,205 2002-08-09
US60/402,209 2002-08-09
US40354802P 2002-08-13 2002-08-13
US40351702P 2002-08-13 2002-08-13
US60/403,548 2002-08-13
US60/403,517 2002-08-13
US40369602P 2002-08-15 2002-08-15
US60/403,696 2002-08-15
US40631802P 2002-08-26 2002-08-26
US60/406,318 2002-08-26
US40620202P 2002-08-27 2002-08-27
US60/406,202 2002-08-27
US10/236,392 US20040067490A1 (en) 2001-09-07 2002-09-06 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US10/236,392 2002-09-06
US10/242,943 2002-09-13
US10/242,943 US20030087412A1 (en) 1998-10-06 2002-09-13 Nlk1 protein and Nlk1 protein complexes
US42313802P 2002-11-01 2002-11-01
US60/423,138 2002-11-01
US10/635,149 2003-08-06
US10/635,149 US20050049192A1 (en) 1999-06-03 2003-08-06 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
PCT/US2003/024931 WO2004015079A2 (fr) 2002-08-07 2003-08-07 Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et leurs procedes d'utilisation

Publications (1)

Publication Number Publication Date
CA2495563A1 true CA2495563A1 (fr) 2004-02-19

Family

ID=31722010

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002495563A Abandoned CA2495563A1 (fr) 2002-08-07 2003-08-07 Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et leurs procedes d'utilisation

Country Status (5)

Country Link
EP (1) EP1539807A4 (fr)
JP (1) JP2006515753A (fr)
AU (1) AU2003259704A1 (fr)
CA (1) CA2495563A1 (fr)
WO (1) WO2004015079A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4863452B2 (ja) * 2006-03-30 2012-01-25 国立大学法人 千葉大学 ヒトＴｈ１／Ｔｈ２分化誘導系及びその用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5846770A (en) * 1994-11-22 1998-12-08 Genetics Institute, Inc. DNA molecules encoding human chordin
PT1632499E (pt) * 1999-03-08 2007-09-11 Genentech Inc Dispositivo de detecção de impacto para automóveis.
AU4196801A (en) * 2000-03-02 2001-09-12 Amgen Inc Chordin-like-2 molecules and uses thereof
AU2002243495A1 (en) * 2001-01-12 2002-07-24 University Of Medicine And Dentistry Of New Jersey Bone morphogenetic protein-2 in the treatment and diagnosis of cancer
US20030134790A1 (en) * 2002-01-11 2003-07-17 University Of Medicine And Dentistry Of New Jersey Bone Morphogenetic Protein-2 And Bone Morphogenetic Protein-4 In The Treatment And Diagnosis Of Cancer

Also Published As

Publication number Publication date
WO2004015079A2 (fr) 2004-02-19
AU2003259704A1 (en) 2004-02-25
JP2006515753A (ja) 2006-06-08
WO2004015079A3 (fr) 2004-09-02
EP1539807A4 (fr) 2006-09-06
EP1539807A2 (fr) 2005-06-15

Similar Documents

Publication Publication Date Title
CA2486490A1 (fr) Polypeptides therapeutiques, acides nucleiques les codant et principes d'utilisation
US20030199442A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US20030219823A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2003078572A2 (fr) Polypeptides therapeutiques, acides nucleiques codant pour ceux-ci et procedes d'utilisation
EP1572922A2 (fr) Polypeptides therapeutiques, acides nucleiques codant pour eux et leur procede d'utilisation
WO2003085124A2 (fr) Polypeptides therapeutiques, acides nucleiques codant pour ceux-ci et methodes d'utilisation associees
US20060234255A1 (en) Novel proteins and nucleic acids encoding same
US20030229016A1 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
US20040067505A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2004089282A2 (fr) Polypeptides therapeutiques, acides nucleiques codant ces polypeptides, et procedes d'utilisation correspondants
CA2471480A1 (fr) Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et procedes d'utilisation
US20040229779A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
CA2481039A1 (fr) Polypeptides therapeutiques, acides nucleiques les codant et leurs procedes d'utilisation
CA2495563A1 (fr) Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et leurs procedes d'utilisation
US20050037957A1 (en) Novel proteins and nucleic acids encoding same
US20040002453A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
CA2485089A1 (fr) Polypeptides therapeutiques, acides nucleiques codant pour lesdits polypeptides et methodes d'utilisation
US20060234257A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
CA2467721A1 (fr) Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et methodes d'utilisation
US20040259774A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US20050049192A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US20040058347A1 (en) Novel proteins and nucleic acids encoding same
EP1565199A2 (fr) Polypeptides therapeutiques, acides nucleiques codant ces polypeptides et methodes d'utilisation
AU2003210852A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2004015076A2 (fr) Nouvelles proteines et acides nucleiques les codant

Legal Events

Date Code Title Description
FZDE Dead